Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; CR; complete response; DEE; drug-eluting embolic; ÎPBV; change in median parenchymal blood volume; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PBV; parenchymal blood volume; PD; progressive disease; PR;
مقالات ISI معیارهای ارزیابی واکنش در تومورهای جامد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; CI; confidence interval; CR; complete response; DEE; drug-eluting embolic; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PEG; polyethylene glycol; PR;
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; CI; confidence interval; mRECIST; modified Response Evaluation Criteria in Solid Tumors; RCC; renal cell carcinoma; 90Y; yttrium-90;
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; TACE; Transarterial Chemoembolization; cTACE; conventional Transarterial Chemoembolization; HCC; hepatocellular carcinoma; EASL; European Association for the Study of the Liver Guidelines; qEASL; 3D quantitative European Association for the Study of the L
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; Transarterial therapy; follow-up; hepatic malignancy; survey; IO; Interventional Oncology; IR; Interventional Radiology; LRT; locoregional therapy; SIR; Society of Interventional Radiology; CT; computed tomography; TACE; transarterial chemoembolization; c
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; SBRT; stereotactic body radiation therapy; HCC; hepatocellular carcinoma; RECIST; response evaluation criteria in solid tumors; CTCAE; common terminology criteria for adverse events; LC; local control; OS; overall survival; PFS; progression-free survival;
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; Outcome; Liver Cancer; Therapy; Hepatic; AUROC; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; HAP; hepatic arterial embolization prognostic; HCC; hepatocellular carcinoma; HR; hazard ratio; mHAP; modified hepatic arterial embolization prog
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; HCC; hepatocellular carcinoma; TACE; transarterial chemoembolization; OS; overall survival; EASL; European Association for the Study of the Liver; mRECIST; modified Response Evaluation Criteria in Solid Tumors; CT; computed tomography; CR; complete respon
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; CI; confidence interval; CR; complete response; CTP; Child-Turcotte-Pugh; DFS; disease-free survival; HCC; hepatocellular carcinoma; MELD; Model for End-Stage Liver Disease; mRECIST; modified Response Evaluation Criteria In Solid Tumors; SBRT; stereot
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; AFP; α-fetoprotein; AUC; area under the curve; BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; IL; interleukin; mRECIST; modified Response Evaluation Criteria In Solid Tumors; NLR; neutrophil-to-lymphocyte ratio; RE; radioembolization
Dual-Energy CT-Derived Volumetric Iodine Concentration for the Assessment of Therapeutic Response after Microwave Ablation in a Rabbit Model with Intrahepatic VX2 Tumor
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; HCC; hepatocellular carcinoma; ICC; intraclass correlation coefficient; mRECIST; modified Response Evaluation Criteria In Solid Tumors; MW; microwave; VIC; volumetric iodine concentration;
Multicenter Phase II Clinical Trial of Sorafenib Combined with Transarterial Chemoembolization for Advanced Stage Hepatocellular Carcinomas (Barcelona Clinic Liver Cancer Stage C): STAB Study
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; AE; adverse event; AFP; alpha fetoprotein; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria in Solid Tumors; OS; overall survival; PVTT;
Progression of Treated versus Untreated Liver Imaging Reporting and Data System Category 4 Masses after Transcatheter Arterial Embolization Therapy
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; APHE; arterial phase hyperenhancing; CI; confidence interval; HCC; hepatocellular carcinoma; LI-RADS; Liver Imaging Reporting and Data System; LR; LI-RADS category; mRECIST; modified Response Evaluation Criteria in Solid Tumors;
Hepatocellular carcinoma treated with sorafenib: Arterial tumor perfusion in dynamic contrast-enhanced CT as early imaging biomarkers for survival
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; HCC; hepatocellular carcinoma; CT; computed tomography; MRI; magnetic resonance imaging; mRECIST; modified response evaluation criteria in solid tumors; TACE; transarterial chemoembolization; HAIC; hepatic arterial infusion chemotherapy; ECOG PS; eastern
Radiation Segmentectomy versus Selective Chemoembolization in the Treatment of Early-Stage Hepatocellular Carcinoma
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; CI; confidence interval; CR; complete response; HCC; hepatocellular carcinoma; HR; hazard ratio; IQR; interquartile range; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PR; partial response; PSM; propensity score matching; RS; radiation
Transarterial Chemoembolization with Small Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: Experience from a Cohort of 421 Patients at an Italian Center
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; DEE; drug-eluting embolic; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; ORR; overall res
Tumor Dose Response in Yttrium-90 Resin Microsphere Embolization for Neuroendocrine Liver Metastases: A Tumor-Specific Analysis with Dose Estimation Using SPECT-CT
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; CR; complete response; HCC; hepatocellular carcinoma; LSF; lung shunt fraction; mRECIST; Modified Response Evaluation Criteria in Solid Tumors; NET; neuroendocrine tumor; PD; progressive disease; PR; partial response; SD; stable disease; SPECT; single pho
The Role of Dual-Phase Cone-Beam CT in Predicting Short-Term Response after Transarterial Chemoembolization for Hepatocellular Carcinoma
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; CI; confidence interval; CR; complete response; HCC; hepatocellular carcinoma; HU; Hounsfield unit; mRECIST; modified Response Evaluation Criteria in Solid Tumors; PD; progressive disease; PR; partial response; ROI; region of interest; SD; stable disease;
Transarterial Chemoembolization of Renal Cell Carcinoma: A Prospective Controlled Trial
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; DEE; drug-eluting embolic; mRECIST; modified Response Evaluation Criteria In Solid Tumors; NSS; nephron-sparing surgery; RCC; renal cell carcinoma; RN; radical nephrectomy; TAE; transarterial embolization; VAS; visual analog scale;
Modified Response Evaluation Criteria in Solid Tumors and European Association for the Study of the Liver Criteria Using Delayed-Phase Imaging at an Early Time Point Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma following
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; CR; complete response; EASL; European Association for the Study of the Liver; ICC; intrahepatic cholangiocarcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PD; progressive disease; PR; partial response; RECIST; Response Evaluation
Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and Future Directions
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; AFP; α-fetoprotein; ECOG; Eastern Cooperative Oncology Group; EASL; European Association for Study of the Liver; FDA; Food and Drug Administration; FDG; fluorodeoxyglucose; HCC; hepatocellular carcinoma; MAA; macroaggregated albumin; mRECIST; modified Re
Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; CNS; central nervous system; K-RAS; Kirsten rat sarcoma; mRECIST; modified Response Evaluation Criteria in Solid Tumors; MRI; magnetic resonance imaging; NSCLC; non-small cell lung cancer; pts; patients; PET-CT; positron emission tomography-computer tomog
Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; CTCAE; Common Terminology Criteria for Adverse Events; IRE; irreversible electroporation; LRFS; local recurrence-free survival; mRECIST; modified Response Evaluation Criteria In Solid Tumors;
Diffusion-Weighted MR Imaging of Hepatocellular Carcinoma: Current Value in Clinical Evaluation of Tumor Response to Locoregional Treatment
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; ADC; apparent diffusion coefficient; DWI; diffusion-weighted imaging; EASL; European Association for the Study of the Liver; EPI; echoplanar imaging; HCC; hepatocellular carcinoma; LRT; locoregional therapy; mRECIST; modified Response Evaluation Criteria
Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting Criteria
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; CR; complete response, EASL = European Association for the Study of the Liver; HCC; hepatocellular carcinoma; MAA; macroaggregated albumin; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PET; positron emission tomography; PFS; progression
Safety and Efficacy of 70-150 μm and 100-300 μm Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; BCLC; Barcelona Clinic Liver Cancer; DEB; drug-eluting bead; DEE; drug-eluting embolic; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors;
Research ArticleOptimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; LT; liver transplantation; HCC; hepatocellular carcinoma; TACE; transarterial chemoembolization; CT; computed tomography; RECIST; Response Evaluation Criteria In Solid Tumors; mRECIST; modified Response Evaluation Criteria In Solid Tumors; IQR; interquart
Yttrium-90 Glass-Based Microsphere Radioembolization in the Treatment of Hepatocellular Carcinoma Secondary to the Hepatitis B Virus: Safety, Efficacy, and Survival
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; AFP; α-fetoprotein; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; ECOG; Eastern Cooperative Oncology Group; HBV; hepatitis B virus; HBV-HCC; hepatocellular carcinoma resulting from hepatitis B virus etiology; HCC; hepatocellular carcinoma
Baseline and Early MR Apparent Diffusion Coefficient Quantification as a Predictor of Response of Unresectable Hepatocellular Carcinoma to Doxorubicin Drug-Eluting Bead Chemoembolization
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; ADC; apparent diffusion coefficient; AUC; area under the curve; CR; complete response; DEB; drug-eluting bead; DWI; diffusion-weighted imaging; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; LRT; locoregional therapy
Degradable Starch Microspheres versus Ethiodol and Doxorubicin in Transarterial Chemoembolization of Hepatocellular Carcinoma
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BCLC; Barcelona Clinic Liver Cancer; DSM; degradable starch microsphere; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors;
Transcatheter Arterial Chemoembolization with Doxorubicin-Eluting Superabsorbent Polymer Microspheres in the Treatment of Hepatocellular Carcinoma: Midterm Follow-up
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; BCLC; Barcelona Clinic Liver Class; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; OLT; orthotopic liver transplantation; SAE; serious adverse event; SAP; superabsorbent polymer;
Serum MicroRNA-210 as a Predictive Biomarker for Treatment Response and Prognosis in Patients with Hepatocellular Carcinoma undergoing Transarterial Chemoembolization
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; AFP; α-fetoprotein; BCLC; Barcelona Clinic Liver Cancer; CR; complete response; HCC; hepatocellular carcinoma; miRNA; microRNA; miR-210; microRNA-210; mRECIST; modified Response Evaluation Criteria in Solid Tumors; OS; overall survival; PD; progressive d
Single-center Comparison of Three Chemoembolization Regimens for Hepatocellular Carcinoma
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; CDM; cisplatin/doxorubicin/mitomycin-c/ethiodized oil; CR; complete response; DE; doxorubicin/ethiodized oil; DEB; drug-eluting bead; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria in Solid Tumors; PACS; picture archiving an
Cancer Concepts and Principles: Primer for the Interventional Oncologist-Part I
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; CR; complete response; DCR; disease control rate; EASL; European Association for the Study of the Liver; FDA; Food and Drug Administration; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria in Solid Tumors; NCCN; National Compr
Downstaging Disease in Patients with Hepatocellular Carcinoma Outside of Milan Criteria: Strategies Using Drug-eluting Bead Chemoembolization
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; AFP; α- fetoprotein; CI; confidence interval; DEB; doxorubicin-eluting bead; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; UCSF; University of California, San Fran
Assessment of Chemotherapy Response in Colorectal Liver Metastases in Patients Undergoing Hepatic Resection and the Correlation to Pathologic Residual Viable Tumor
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; DFS; disease-free survival; mRECIST; modified Response Evaluation Criteria in Solid Tumors; OS; overall survival; RECIST; Response Evaluation Criteria in Solid Tumors; SVM; semi-automated volume method;
Research ArticleMaximum number of target lesions required to measure responses to transarterial chemoembolization using the enhancement criteria in patients with intrahepatic hepatocellular carcinoma
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; mRECIST; modified Response Evaluation Criteria in Solid Tumors; WHO; World Health Organization; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; TACE; transarterial chemoembolization; BCLC; Barcelona Clinic Liver Cance
Yttrium-90 Radioembolization of Renal Cell Carcinoma Metastatic to the Liver
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; MAA; microaggregated albumin; mRECIST; modified Response Evaluation Criteria in Solid Tumors; PET; positron emission tomography; RCC; renal cell carcinoma; RECIST; Response Evaluation Criteria in Solid Tumors; 90Y; yttrium-90;
Quantitative and VolumetricEuropean Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors Measurements: Feasibility of a Semiautomated Software Method to Assess Tumor Response after Transcatheter Arterial Chemoembolizatio
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; DEB; drug-eluting beads; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria in Solid Tumors; qEASL; quantitative EASL; RECIST; Response Evaluation Criteria in Solid Tumors;
Clinical Utility of Des-γ-Carboxy Prothrombin Kinetics as a Complement to Radiologic Response in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Keywords: معیارهای ارزیابی واکنش در تومورهای جامد; AFP; α-fetoprotein; CR; complete response; DCP; des-γ-carboxy prothrombin; HCC; hepatocellular carcinoma; HR; hazard ratio; IQR; interquartile range; mRECIST; modified Response Evaluation Criteria In Solid Tumors; OS; overall survival; PD; progressive d